Alkermes (ALKS) Goodwill & Intangibles (2011 - 2026)
Alkermes' (ALKS) quarterly Goodwill & Intangibles came in at $2.3 billion in Q1 2026, up 2637.87% year-on-year from $83.9 million in Q1 2025, and up 2639.73% on a QoQ basis from $83.8 million in Q4 2025.
Alkermes (ALKS) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Goodwill & Intangibles data on file, last reported at $2.3 billion in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 2637.87% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 2637.87% increase from a year earlier, with the FY2025 full-year figure at $83.8 million, changed 0.09% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $2.3 billion, up from $83.8 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for ALKS reached as high as $2.3 billion in Q1 2026 and fell as low as $83.8 million in Q4 2025.
- Historically, Goodwill & Intangibles has averaged $364.0 million across 5 years, with a median of $85.0 million in 2023.
- Across the five-year window, Goodwill & Intangibles tumbled 87.6% in 2024 and surged 2637.87% in 2026, its largest moves.
- Year by year, Goodwill & Intangibles stood at $120.7 million in 2022, then fell by 29.57% to $85.0 million in 2023, then slipped by 1.3% to $83.9 million in 2024, then fell by 0.09% to $83.8 million in 2025, then surged by 2639.73% to $2.3 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $2.3 billion in Q1 2026, $83.8 million in Q4 2025, and $83.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Bn |
| Dec 31, 2025 | 83.84 Mn |
| Sep 30, 2025 | 83.86 Mn |
| Jun 30, 2025 | 83.88 Mn |
| Mar 31, 2025 | 83.90 Mn |
| Dec 31, 2024 | 83.92 Mn |
| Sep 30, 2024 | 83.93 Mn |
| Jun 30, 2024 | 83.95 Mn |
| Mar 31, 2024 | 83.96 Mn |
| Dec 31, 2023 | 85.02 Mn |
| Sep 30, 2023 | 676.62 Mn |
| Jun 30, 2023 | 676.62 Mn |
| Mar 31, 2023 | 676.62 Mn |
| Dec 31, 2022 | 120.71 Mn |
| Sep 30, 2022 | 676.62 Mn |
| Jun 30, 2022 | 148.88 Mn |
| Mar 31, 2022 | 157.95 Mn |
| Dec 31, 2021 | 166.92 Mn |
| Sep 30, 2021 | 676.62 Mn |
| Jun 30, 2021 | 186.15 Mn |